amdinocillin has been researched along with amoxicillin-potassium clavulanate combination in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerfoot, P; McGhie, D; Talbot, DJ | 1 |
| Fennell, JP; Kavanagh, S; Manecksha, R; O'Kelly, F; Thornhill, J | 1 |
| Bidet, P; Birgy, A; Bonacorsi, S; Caseris, M; Delecourt, M; Desselas, E; Geslain, G; Magnan, M; Mariani-Kurkdjian, P | 1 |
| Lagerbäck, P; Montelin, H; Shams, A; Skarp, KP; Tängdén, T | 1 |
1 trial(s) available for amdinocillin and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
A comparative study of Miraxid (pivmecillinam plus pivampicillin) and Augmentin (amoxycillin plus clavulanic acid) in the treatment of lower respiratory tract infections in general practice.
Topics: Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Bronchitis; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Family Practice; Female; Humans; Male; Middle Aged; Pivampicillin | 1986 |
3 other study(ies) available for amdinocillin and amoxicillin-potassium clavulanate combination
| Article | Year |
|---|---|
Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
Topics: Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; General Practice; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Hospitals; Humans; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nursing Homes; Pilot Projects; Prevalence; Prospective Studies; Risk Factors; Urinary Tract Infections | 2016 |
A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
Topics: Amdinocillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; France; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Penicillinase; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Urinary Tract Infections | 2017 |
Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Topics: Amdinocillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests | 2019 |